CADASIL is a rare, inherited type of vascular disease (a disease of the blood vessels such as arteries and veins) that can cause dementia. CADASIL stands for 'Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy'. CADASIL is caused by a faulty gene.
Άλλες ερωτήσεις χρηστών
What is the life expectancy of CADASIL?
What are the first symptoms of CADASIL?
Is there a cure for CADASIL?
What is the cause of death in CADASIL?
Rapid onset of vertigo, nausea/vomiting, and abnormal gait in association with head-motion intolerance and abnormal eye movements (acute vestibular syndrome).
1 Απρ 2019 · Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, usually called CADASIL, is an inherited condition
Έγινε επίσης αναζήτηση για
Rare Caregiver Respite Program. This first-of-its-kind assistance program is designed for caregivers of a child or adult diagnosed with a rare disorder.
CADASIL or CADASIL syndrome, involving cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, is the most common form ...
CADASIL is a rare genetic disorder with no cure. The condition is best managed by an interprofessional team that includes pharmacists, nurses and geneticists.
CADASIL
Ασθένεια
>
Το σύνδρομο CADASIL ή CADASIL, που περιλαμβάνει εγκεφαλική αυτοσωματική επικρατούσα αρτηριοπάθεια με υποφλοιώδη εμφράγματα και λευκοεγκεφαλοπάθεια, είναι η πιο κοινή μορφή κληρονομικής διαταραχής εγκεφαλικού επεισοδίου και πιστεύεται ότι... Wikipedia (Αγγλικά)
CADASIL is characterized by migraine headaches and multiple strokes progressing to dementia. Other symptoms include cognitive deterioration, seizures, vision ...
9 Οκτ 2018 · Pathophysiology. CADASIL is caused by a mutation in the NOTCH3 gene on chromosome 19q12. The gene mutation was first identified in 1996.
22 Νοε 2023 · Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Formulary drug information for this ...
18 Απρ 2024 · CADASIL is an autosomal dominant trait, with patients typically becoming symptomatic in adulthood (30 to 50 years of age). Clinical ...